EPSRC IAA: A Predictive Risk Model to Monitor Immunotherapy Patients and Advance the Commercial Case to Spin-out Company

Project: Research - Internally Allocated

Project Details

StatusActive
Effective start/end date1/04/2231/03/26

Funding

  • EPSRC (Engineering and Physical Sciences Research Council): £49,251.31